BRIEF-Qyuns Therapeutics Says On June 4, Co Entered Subscription Agreement With ICBC

Reuters07-02

July 2 (Reuters) - Qyuns Therapeutics Co Ltd :

* ON JUNE 4, CO ENTERED SUBSCRIPTION AGREEMENT WITH ICBC TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS FOR RMB50 MILLION

* ON APRIL 18 AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY BANK OF JIANGSU WITH SUBSCRIPTION AMOUNT OF RMB50 MILLION

* ON MAY 29. AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY SHANGHAI PUDONG DEVELOPMENT BANK OF RMB100 MILLION

* ON APRIL 12 AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY SHANGHAI PUDONG DEVELOPMENT BANK OF RMB60 MILLION

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2448157421?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-02 22:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2448157421","market":"sh","top_or_hot":-1,"title":"BRIEF-Qyuns Therapeutics Says On June 4, Co Entered Subscription Agreement With ICBC","media":"Reuters","content":"<html><body><p>July 2 (Reuters) - Qyuns <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Co Ltd   :</p><p>   * ON JUNE 4, CO ENTERED SUBSCRIPTION AGREEMENT WITH ICBC TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS FOR RMB50 MILLION</p><p>   * ON APRIL 18 AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY BANK OF JIANGSU WITH SUBSCRIPTION AMOUNT OF RMB50 MILLION</p><p>   * ON MAY 29. AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY SHANGHAI PUDONG DEVELOPMENT BANK OF RMB100 MILLION</p><p>   * ON APRIL 12 AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY SHANGHAI PUDONG DEVELOPMENT BANK OF RMB60 MILLION</p><p>Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Qyuns Therapeutics Says On June 4, Co Entered Subscription Agreement With ICBC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Qyuns Therapeutics Says On June 4, Co Entered Subscription Agreement With ICBC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-02 22:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>July 2 (Reuters) - Qyuns Therapeutics Co Ltd   :   * ON JUNE 4, CO ENTERED SUBSCRIPTION AGREEMENT WITH ICBC TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS FOR RMB50 MILLION   * ON APRIL 18 AGREED TO ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2448157421","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2448157421","pubTimestamp":1719929417,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"July 2  - Qyuns Therapeutics Co Ltd   :   * ON JUNE 4, CO ENTERED SUBSCRIPTION AGREEMENT WITH ICBC TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS FOR RMB50 MILLION   * ON APRIL 18 AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY BANK OF JIANGSU WITH SUBSCRIPTION AMOUNT OF RMB50 MILLION   * ON MAY 29. AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY SHANGHAI PUDONG DEVELOPMENT BANK OF RMB100 MILLION   * ON APRIL 12 AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY SHANGHAI PUDONG DEVELOPMENT BANK OF RMB60 MILLIONFurther company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B","BK1161":"生物科技"},"translate_title":"BRIEF-Qyuns Therapeutics表示，6月4日，Co与工商银行签订认购协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":0.9},"content_text":"July 2 (Reuters) - Qyuns Therapeutics Co Ltd   :   * ON JUNE 4, CO ENTERED SUBSCRIPTION AGREEMENT WITH ICBC TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS FOR RMB50 MILLION   * ON APRIL 18 AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY BANK OF JIANGSU WITH SUBSCRIPTION AMOUNT OF RMB50 MILLION   * ON MAY 29. AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY SHANGHAI PUDONG DEVELOPMENT BANK OF RMB100 MILLION   * ON APRIL 12 AGREED TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS OFFERED BY SHANGHAI PUDONG DEVELOPMENT BANK OF RMB60 MILLIONFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2448157421"}